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enriched for disease-associated genetic variants
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Abstract 
Background: Stretch enhancers (SEs) are large chromatin-defined regulatory elements that are at least 3,000 base 
pairs (bps) long, in contrast to the median enhancer length of 800 bps. SEs tend to be cell-type specific, regulate cell-
type specific gene expression, and are enriched in disease-associated genetic variants in disease-relevant cell types. 
Transcription factors (TFs) can bind to enhancers to modulate enhancer activity, and their sequence specificity can be 
represented by motifs. We hypothesize motifs can provide a biological context for how genetic variants contribute to 
disease.
Results: We integrated chromatin state, gene expression, and chromatin accessibility [measured as DNase I Hyper-
sensitive Sites (DHSs)] maps across nine different cell types. Motif enrichment analyses of chromatin-defined enhancer 
sequences identify several known cell-type specific “master” factors. Furthermore, de novo motif discovery not only 
recovers many of these motifs, but also identifies novel non-canonical motifs, providing additional insight into TF 
binding preferences. Across the length of SEs, motifs are most enriched in DHSs, though relative enrichment is also 
observed outside of DHSs. Interestingly, we show that single nucleotide polymorphisms associated with diseases or 
quantitative traits significantly overlap motif occurrences located in SEs, but outside of DHSs.
Conclusions: These results reinforce the role of SEs in influencing risk for diseases and suggest an expanded regu-
latory functional role for motifs that occur outside highly accessible chromatin. Furthermore, the motif signatures 
generated here expand our understanding of the binding preference of well-characterized TFs.
© 2015 Quang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Chromatin immunoprecipitation combined with high-
throughput sequencing (ChIP-seq) can identify the 
genome-wide locations of target proteins, including tran-
scription factors (TFs), RNA Polymerase II, and cova-
lently modified histones [1]. ChIP-seq datasets for several 
chromatin marks and the sequence-specific factor CTCF 
can be computationally integrated to discover combina-
torial and spatial patterns that produce a consistent anno-
tation of promoter, enhancer, insulator, transcribed, and 
repressed chromatin states. In a recent study, we profiled 
the chromatin states of several cell lines using Chrom-
HMM [2], which revealed the presence of large gene 
control elements that we designated “stretch enhancers” 
(referred to as SEs in this paper) [3]. By our definition, 
SEs have a length of at least 3,000 DNA base pairs (bps) 
and are much larger than typical enhancers (TEs), which 
we defined to be any enhancer less than or equal to the 
median enhancer length of 800 bps. SEs are generally cell 
type specific, associated with increased cell-specific gene 
expression, and tend to harbor disease-relevant genetic 
variants derived from genome-wide association stud-
ies (GWASs). In our previous paper [3], we showed that 
enrichment for GWAS variants increases with the length 
of enhancers, but we did not try to define the precise 
relationship of GWAS variants to motifs located within 
the enhancers—that is the goal of this paper. SEs share 
several traits with another recently defined class of large 
enhancers designated super-enhancers by Young and 
colleagues [4, 5]. Like SEs, super-enhancers drive cell-
type-specific gene expression; however, super-enhancers 
have been defined by the disproportionate abundance of 
Mediator or histone 3 lysine 27 acetylation (H3K27ac) 
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signal [6], whereas SEs are defined by patterns of histone 
modifications, or chromatin states. Enhancers can func-
tion independently of their endogenous spatial contexts, 
which is a property exploited in luciferase assays to meas-
ure enhancer activity by placing enhancers upstream 
of reporter genes. This suggests that the information 
required for the enhancer activity is encoded in the 
underlying DNA sequences. We, therefore, hypothesize 
that the sequence content of the enhancers can provide 
additional insight into the relationship between enhancer 
function and enhancer length, which we address by stud-
ying how SEs differ from TEs.
Enhancer sequences are known to be enriched for 
transcription factor binding sites, which contribute to 
enhancer activity. Upon binding to their recognition 
motifs, some TF proteins can form complexes with other 
proteins, which can alter the 3D conformation of chro-
matin and recruit RNA Polymerase II to promote the 
transcription of target genes located in cis, sometimes 
at considerable distances. The motif, or sequence bind-
ing specificity, for a TF can be represented as a posi-
tion weight matrix (PWM) that specifies the nucleotide 
frequency at each position along the binding sequence. 
Recently, less complex nucleotide patterns—like dinu-
cleotide repeats—were shown to contribute to enhancer 
activity [7].
In this study, we analyze the motif signatures of SEs 
and how they differ from those of TEs. We scan enhancer 
sequences using known motifs from databases to iden-
tify TFs that are characteristic of each cell type studied, 
which we are also able to recover using de novo motif 
discovery. We investigate how GWAS single nucleotide 
polymorphisms (SNPs) can affect TF motif signatures 
in SEs, which can provide important clues about how 
genetic variations contribute to disease risk.
Results and discussion
Systematic chromatin state, DNase hypersensitivity, 
and gene expression profiling across nine diverse cell 
types
In our previous study, we used the ChromHMM algo-
rithm to systematically integrate ChIP-seq histone 
modification and CTCF datasets and uniformly profile 
chromatin states across ten diverse cell types. These 
ChromHMM segmentations are used to profile SEs, 
which are defined as regions of at least 3,000 bps con-
taining contiguous segments marked as enhancer states. 
TEs are defined similarly, but are less than or equal to 
800 bps in length. Although SEs only constitute the top 
10% of enhancers in terms of length, they represent a 
disproportionately large percentage of the total number 
of nucleotides among all enhancers (Additional file  1: 
Table S1).
Of the ten cell types profiled, nine also have DNase-seq 
data available. DNase-seq is a method used to identify 
the genome-wide locations of DHSs, which are regions 
of the genome that are highly sensitive to cleavage by 
DNase I and mark regulatory elements such as enhancers 
and promoters [8]. DHSs generally mark regions that are 
more accessible for TF binding and are enriched for TF 
binding motifs.
Figure 1a displays the accessible chromatin, chromatin 
state, and gene expression profiles across the nine cell 
types around the ABCC8 locus. Gene expression RNA-
seq [9] tracks clearly show that the ABCC8 transcript is 
exclusively expressed in the islet sample, and the chroma-
tin state tracks show this gene body is covered by several 
islet-specific SEs. This integrative approach can identify 
cell-specific chromatin and expression profiles to provide 
a basis for further understanding the functional effects of 
SNPs in common, complex diseases. In the ABCC8 exam-
ple, lead type 2 diabetes (T2D) GWAS SNPs (red arrow 
heads) and several linked SNPs (r2  ≥  0.8) (green bars) 
overlap islet-specific chromatin states. Enhancers have 
been shown to overlap multiple linked SNPs more often 
than expected at random [3, 10], suggesting that multiple 
enhancer variants work together in concert to alter gene 
expression and contribute to disease susceptibility.
From the ABCC8 example, we can infer some properties 
about the interplay between chromatin states and DNase 
I hypersensitivity in SEs. First, we notice that the SEs 
encompass several DHSs, but the entire SE does not dis-
play DNase hypersensitivity. Unsurprisingly due to their 
length, SEs contain proportionately more DHSs than TEs 
do (Additional file 2: Figure S1). Second, strong enhancer 
states in islets in ABCC8, for example (Figure  1a), tend 
to overlap spikes in the islet DNase-seq signal. By aggre-
gating the DNase-seq tag density relative to DNase-seq 
peak summits in either SEs or TEs, we find there is rela-
tively little difference in DNase I hypersensitivity between 
the classes of enhancers (Figure 1b). However, there is a 
large difference in the H3K27ac ChIP-seq signal (Fig-
ure 1c). Notably, there is a dip in the H3K27ac signal in 
the center of the DNase peak summit, which is a reflec-
tion of bound TFs that can displace histones. This TF-
induced configuration of chromatin architecture is much 
more pronounced in SEs than it is in TEs. Of relevance, 
this H3K27ac dip feature recently provided the central 
motivation for a novel computational algorithm to detect 
factor binding sites [11]. Given the pronounced dip in SEs 
versus TEs, this recent computational algorithm likely 
picked up mostly on SE-mediated factor binding sites. 
In generating the signal histogram plots, we accounted 
for the minor difference in mappability between SEs 
and TEs. Generally, SEs are slightly more mappable than 
TEs (Additional file 2: Figure S2), which suggests that SE 
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sequences are less repetitive and more complex than TEs. 
Such sequence composition differences could be charac-
teristic of the two enhancer classes. Nevertheless, even 
after accounting for differences in mappability, there is 
still a large statistical difference in H3K27ac signal across 
the length of the enhancers (Additional file 2: Figure S3).
Figure 1 Systematic profiling of DNase I hypersensitivity, chromatin states, and gene expression across nine cell types. a Chromatin states and 
DNase I hypersensitivity density tracks in and around the ABCC8 locus. Human pancreatic islet chromatin states are similar to some of the other 
ENCODE cell types at the commonly expressed flanking gene NCR3LG1 and unique at the islet-specific expressed gene ABCC8. (Upper) DNase I 
Hypersensitivity Density Signal from ENCODE/Duke in dense format for each of nine human cell types (islets; GM12878, lymphoblastoid cells; H1 
ES, embryonic stem cells; HepG2, hepatocellular carcinoma; HMEC, mammary epithelial cells; HSMM, smooth muscle myoblasts; HUVEC, umbilical 
vein endothelial cells, K562, erythroleukemia cells, NHEK, keratinocytes). Density graphs (wiggles) of signal enrichment calculated using F-Seq are 
displayed in grayscale. Scale is from 0 to 0.1. (Middle) ChromHMM-defined chromatin states. Chromatin state assignments are indicated in the top-
leftmost key. (Lower) RNA-seq-based expression for each cell type is measured in reads per million mapped reads (RPM) per base pair. Scale is from 0 
to 2 for each cell type. Index and tightly linked (r2 ≥ 0.8) SNPs associated with T2D are indicated in green in the T2D GWAS SNPs track and primarily 
reside in islet-specific SEs. Index SNPs rs5215 and rs5219 are marked with red arrows. The black box highlights a portion of the SE previously shown 
to direct tissue-specific expression patterns in a spatial and temporal manner in vivo [3]. All processed results are browsable and downloadable at 
http://research.nhgri.nih.gov/manuscripts/Collins/isletchromatin/. b–d Aggregate DNase-seq tag density (b), H3K27ac ChIP-seq tag density, (c), and 
(d) CG dinucleotide frequency profiles of 3kbp sequences centered on DNase-seq peak summits—the location of the highest DNase-seq signal—
located within SEs or TEs. e DHSs within SEs are much closer together than they are within TEs (two-tailed Wilcoxon rank sum test, p < 10−100 for all 
cell types). Boxplots show the distance, for each SE or TE DNase-seq summit, to the nearest SE or TE DNase-seq summit, respectively, for all cell types. 
f DHSs within SEs are moderately longer than DHSs within TEs (two-tailed Wilcoxon rank sum test, p < 10−5 for all cell types). Boxplots show the 
length of each DHS whose summit overlaps a SE or TE. Boxplot whiskers extend to 1.5× the interquartile range and outliers are shown as block dots, 
but the y-axis is truncated so that the boxplots can remain in view. Enhancer classes for b–f are indicated in the top-rightmost key.
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To examine functional and sequence composition dif-
ferences between the two enhancer classes more compre-
hensively, we plotted the average Genomic Evolutionary 
Rate Profiling (GERP) score [12] (Additional file 2: Figure 
S4), a metric that estimates position-specific evolution-
ary constraint across a multi-species sequence alignment, 
and dinucleotide frequencies (Figure 1d, Additional file 2: 
Figure S5) at each position relative to DNase-seq peak 
summits in either SEs or TEs. Generally, SEs and TEs 
show similar patterns of evolutionary constraint around 
DNase-seq peak summits. GERP scores are highest at the 
summit and decrease as one moves away from the sum-
mit. At the summits, SEs have a slightly higher average 
GERP score than TEs. SE and TE sequences are par-
ticularly different in terms of their CG dinucleotide fre-
quencies: both SEs and TEs display a large spike in CG 
frequency in the DHS summits, but TE sequences are 
much more CG-rich and overlap CpG islands more often 
(Additional file 2: Figure S6). Notably, TFs tend to bind to 
CG-rich DNase I accessible regions, but the CG richness 
of some motifs do not account for this spike in CG fre-
quency [13]. The variation in dinucleotide frequencies is 
largely a function of where these enhancers are located in 
the genome relative to gene models (Additional file 2: Fig-
ure S7). When restricted to transcription start site (TSS) 
distal regions, the dinucleotide differences are mitigated, 
but the difference in H3K27ac ChIP-seq signal persists 
(Additional file 2: Figure S8). In some of these histogram 
plots, we note that the differences can persist several 
hundred base pairs away from the center. One possible 
reason for this phenomenon is the proximity between 
DHSs in SEs. Although SEs are much longer than TEs, 
DHSs in SEs are still spaced comparatively close together 
(Figure 1e). DHSs in SEs are also significantly longer than 
DHSs in TEs (Figure 1f ), which suggests that individual 
DHSs in SEs can accommodate more TF binding sites 
than DHSs in TEs can.
Enhancer sequences are enriched for known motifs
Different cell types are regulated by sets of TFs that are 
important for establishing and maintaining cell identity. 
Enhancers are expected to be enriched for motifs that 
serve as putative TF binding sites. We hypothesize that 
DHSs in enhancers should be especially enriched for 
motif sites, because these regions are more accessible 
for protein–DNA interactions. In particular, enhancers 
would be expected to be bound by a specific class of TFs 
called activators, which increase gene transcription.
To identify activator motifs, we searched for a rela-
tionship between motif enrichment and gene expres-
sion, similar in nature to a previous approach [2], and 
demonstrated that the gene expression of activators (by 
mRNA quantification) correlates positively with the 
enrichment of its binding motif in SE DHS sequences 
across the nine cell types. For instance, HNF1A, an acti-
vator highly expressed in the liver, shows a very strong 
positive relationship between its expression across the 
nine cell types and the enrichment of its binding motif 
in SE DHS sequences (Figure  2a). In contrast, repres-
sors such as GFI1 tend to have a negative correlation 
(Figure  2b). These observations reflect the general con-
cept of TF binding cooperativity on the DNA scaffold 
whereby increases in the number of binding sites results 
in increased enhancer activity [14, 15]. We hypothesize 
that enhancer sequences are organized in a way such 
that an increase in expression of the relevant activator is 
accommodated by an increase in available binding sites, 
while reducing potential binding sites for any present 
repressors. To explore this idea more comprehensively, 
we studied the distribution of motif enrichment versus 
gene expression correlations across motif-TF pairs for SE 
DHS sequences, as well as SE non-DHS, TE DHS, and TE 
non-DHS sequences (Figure  2c). All four observed dis-
tributions (red) display a significant positive correlation 
bias relative to the null expectation (blue), indicating that 
SEs and TEs have well-organized motif architecture both 
inside and outside of DHSs. To determine whether the 
relative motif enrichments are the same across different 
enhancer regions, we examine the correlation between 
a motif ’s enrichment in one genomic region against its 
enrichment in a different genomic region (e.g. CTCF 
motif enrichment in SE DHS sequences across cell types 
versus its enrichment in TE DHS sequences across cell 
types). We then measure the distribution of correlations 
between enrichments for all motifs in different pairs of 
regions (Figure  2d). Despite the difference in absolute 
motif enrichments in different enhancer regions, we 
find that the relative motif enrichments are strongly pre-
served. Together, these findings indicate that enhancer 
motif architecture is linked to TF gene expression and 
preserved within and outside DHSs in SEs and TEs.
Next, we investigate how motif enrichments vary 
across different motifs, cell types, and enhancer regions. 
We perform agglomerative clustering on the log2 fold 
enrichment in SE DHS sequences of activator motifs that 
are significantly and differentially enriched in enhancer 
sequences, in order to group motifs in an unsupervised 
fashion (“Methods”). This analysis results in clusters of 
motifs that are grouped corresponding to TF families 
known to play important roles in the cell types consid-
ered, which we visualize with heatmaps of motif enrich-
ment across four different enhancer categories (Figure 3, 
Additional file  2: Figure S9). The heatmaps highlight 
the relative motif enrichments in enhancers between 
and within the cell types, capturing known biologically 
relevant cell-TF associations. For example, the GATA 
Page 5 of 14Quang et al. Epigenetics & Chromatin  (2015) 8:23 
cluster is K562-specific, which is appropriate because 
K562 is an erythroleukemia cell line, so we expect the 
motif of the erythroid fate determining TF GATA-1 [16] 
to be over-represented in K562 enhancers. As expected, 
motifs are most enriched in DHS sequences. Non-DHS 
regions in enhancers are also enriched for some motifs, 
but to a much lesser extent than their DHS counterparts. 
Despite how clustering was performed on enrichment 
values focused on the SE DHS sequences, many of the 
enrichment clusterings in the other enhancer regions are 
preserved (Figure 3, black boxes), further supporting the 
concept of common motif architecture across the differ-
ent enhancer regions.
We next investigate how motifs are spatially distributed 
in SEs and TEs. For each cell type, we generated a set of 
activator motifs that are highly enriched in the respec-
tive SE DHS sequences and computed the density histo-
grams of motif occurrences in SEs or TEs relative to the 
a b
c d
Figure 2 Motif enrichments in enhancers are correlated with the expression of the TFs that bind to these motifs. a, b TFs’ expressions are correlated 
against the enrichment of their respective binding motifs in SE DHS sequences across the nine cell types. The master activator HNF1A (a) has a posi-
tive relationship between gene expression and motif enrichment, while the repressor GFI1 (b) has a negative relationship. The name of the motif, 
Spearman’s correlation (ρ), and sequence logo of the motif are displayed in the corner of the plots. c Boxplots of Spearman’s correlations of enrich-
ments in four different regions for all database motifs against gene expression in the nine cell types. d Boxplots of Spearman’s correlations of motif 
enrichments between two different regions (listed in the strip titles at the top of the facets). For each motif and each pair of regions, we computed 
the enrichments of the motif in both sets of sequences and then computed the Spearman’s correlation between the two sets of enrichments. 
Within each facet, the boxplot of Spearman’s correlations (red, left) is also displayed alongside a boxplot of a null distribution (blue, right) generated 
by recalculating the Spearman’s correlations after shuffling cell assignments for one of the variables. P-values below the boxplots represent the 
significance of the distribution compared to the respective null distributions and are calculated with the Wilcoxon rank sum test. Gene expression 
is measured in reads per kilobase per million (RPKM). Motif sites were identified with FIMO, a tool for searching occurrences of known motifs in 
biological sequences [34]. Motif enrichment is calculated as the ratio of FIMO hits in the positive sequence set to FIMO hits in dinucleotide shuffled 
negative control (“Methods”).
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summits of DNase-seq peaks. Motif density is propor-
tional to DNase I hypersensitivity, being greatest at the 
summits of DNase I hypersensitivity peaks and decreas-
ing away from the summits (Figure 4a, Additional file 2: 
Figure S10). Based on these aggregate plots and heat-
maps, SEs and TEs display similar motif enrichment and 
density patterns in their DHSs. However, SEs represent a 
disproportionately large fraction of enhancers by nucleo-
tide count (Additional file 1: Table S1). Furthermore, SEs 
contain more DHSs per enhancer (Additional file 2: Fig-
ure S1). Therefore, SEs are further set apart from shorter 
enhancers by a proportional increase in putative binding 
sites, but not by differences in motif density or enrich-
ment within or close by to individual DHSs.
To examine how motifs are distributed across indi-
vidual enhancers instead of aggregating across groups of 
enhancers, we generated tracks that display motif densi-
ties in enhancers (Figure 4b, Additional file 2: Figure S11) 
for motifs that are significantly and differentially enriched 
in enhancer sequences of a given cell type, which we refer 
to as cell identity motifs. Again, we observe that cell iden-
tity motifs cluster in DHSs, but we also find that these 
Figure 3 Heatmaps of enrichment of the binding motifs of activator TFs across nine cell types and four regions. Shading indicates log2 enrich-
ment of motifs in sequences of the specified cell and region. (Clustering was done using SE DHS motifs). To improve visualization of the heatmaps, 
the original set of motifs is pruned through a strategy that includes removing any motifs for which the corresponding TF fails to be significantly 
expressed in any of the nine cell types. This pruning strategy reduces the motif set to primarily include motifs of activator and master factors. The 
remaining motifs are clustered and ordered by exemplar-based agglomerative clustering on the log2 enrichment values across the nine cell types 
(“Methods”). Groups or families of motifs are manually labeled on the left side. Black boxes highlight cell-specific motif enrichment clusters.
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Figure 4 Motifs are most enriched around the summits of DNase-seq peaks. a Aggregate motif density plots of 3kbp sequences centered on 
DNase-seq peak summits within SEs or TEs. Line plots are colored as in the enhancer class key in Figure 1. Cell-specific motif sets are generated by 
selecting motifs that are significantly enriched in SE DHS sequences and correspond to TFs that are significantly expressed. Individual motif density 
plots are generated by the Homer annotate Peaks tool [39] with motifs called at a threshold of 40% of the maximum log likelihood score. These 
individual motif density plots are summed together position-wise to generate the aggregate motif density plots (“Methods”). Motif densities are 
generally similar between the SE and TE sequences. b UCSC Genome browser view of the ZBED3-AS1 locus. Motif density tracks (Upper) identify 
portions of the genome assigned an enhancer state that are relatively rich in motifs. These tracks measure the number of non-overlapping motif 
sites in 150 bp windows at 10 bp steps and are auto-scaled for each cell type. Potentially functional SNPs that overlap SEs may not overlap any DHS, 
but may overlap portions of the SEs that are dense in motifs, such as the rightmost T2D tightly linked SNP. Chromatin state colors and scales for the 
other tracks are assigned as in Figure 1a. The black box highlights a strong overlap of cell-specific accessible chromatin and enhancer chromatin 
states that is also dense in motifs. These tracks are downloadable at http://fusion.nhgri.nih.gov/files/se-motifs/motifsBedgraphs.tar.
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motif clusters often appear outside of DHSs. In this par-
ticular example, none of the linked T2D SNPs overlapped 
any DHSs, but they did overlap portions of the islet-spe-
cific SE that is relatively dense in islet cell identity acti-
vator motifs. Interestingly, the RNA-seq tracks show a 
lack of expression of the surrounding ZBED3-AS1 gene, 
implying that the SE is likely acting on a distant gene. 
The lack of DNase hypersensitivity does not necessarily 
exclude the possibility that TFs are binding to these parts 
of SEs, since the specific chromatin marks extending 
across an SE suggest that the entire region is consider-
ably more open than the average genomic segment. One 
possibility is that DNase-seq may not be able to identify 
chromatin accessibility in these particular locations. For 
example, in a comparative study with FAIRE-seq, another 
assay for mapping open chromatin sites, some open chro-
matin sites are unique to either DNase-seq or FAIRE-seq. 
Multiple lines of evidence suggest that these DNase-
only and FAIRE-only sites correspond to real chromatin 
features [17]. It is also of note that some TFs are able to 
localize partially or predominantly within inaccessible 
chromatin [18].
De novo motif discovery in enhancers
Computing enrichment of known motifs in enhancer 
sequences can provide insight into the motif landscape 
of these sequences, but it does not necessarily identify 
the actual set of TFs that bind to the enhancers. This is 
because different TFs can bind to very similar motifs, 
leading to ambiguity. Moreover, motif scanning analy-
sis is limited to motifs that are available in databases, 
which are incomplete. Even for the TFs that are repre-
sented, databases often neglect infrequent non-canonical 
motifs. For example, one study showed that the protein 
Neuron Restrictive Silencer Factor can have, in addition 
to its prominent canonical motif, nine infrequent non-
canonical motifs that are not present in any motif data-
base [19]. In fact, motifs in databases may not accurately 
represent the in vivo binding context of TFs. For exam-
ple, many of the database motifs we consider in this study 
were generated by high-throughput SELEX on single TFs 
[20], an in  vitro assay that can miss important in  vivo 
binding contexts. Additionally, DNA shape-based read-
out by TFs is not well captured by traditional PWMs [21] 
and can, therefore, result in missed target sites. Finally, 
results from a recent study show that disease-associated 
non-coding SNPs are not well captured by PWMs and 
may instead be better explained by non-conical sequence 
determinants [22].
To further explore the motif landscape of enhancers, 
we apply de novo motif discovery on DHS sequences in 
SEs, which we showed are highly enriched for cell spe-
cific regulatory motifs. We also apply de novo motif 
discovery to DNase I “footprints” within all enhancers. 
Footprints are local dips in the DNase I cleavage signal, 
which are predicted to demarcate TF occupancy because 
TFs protect accessible chromatin from DNase I cleavage 
[23–25]. Therefore, footprint sequences should be much 
more enriched for motifs than the larger DHS sequences 
and can significantly improve the quality of de novo motif 
discovery. Due to the large number of nucleotides in the 
sequences we scan, we use EXTREME [19], a fast motif 
discovery algorithm designed for large sequence datasets. 
As a demonstration of the effectiveness of this approach, 
EXTREME is able to recover motifs that significantly 
match known signatures (Figure 5, Additional file 2: Fig-
ure S12). These motifs often correspond to TFs known 
to be associated with cellular differentiation and repro-
gramming (Additional file 3).
The de novo motif discovery analysis does not yield 
any prominent examples of novel motif families, possi-
bly because the systems we consider have already been 
studied extensively. However, we do find that de novo 
motif discovery can provide novel insight into the spa-
tial arrangement of motif combinations at nucleotide 
resolution. Some of the motifs discovered in footprint 
sequences appear as combinations of two known motifs 
Figure 5 De novo motif discovery accurately recovers known motifs. 
Examples of sequence motifs that are enriched in Stretch Enhancer 
(SE) DNase Hypersensitive Site (DHS) sequences or within DNase 
footprints (FP) across all ChromHMM concatenated enhancers (CEs). 
Sequences of motifs derived from EXTREME (bottom) are aligned to 
known motifs from two databases [20, 37] (top). Motif similarity was 
measured with TOMTOM, a tool that reports the significance of a 
match between a query motif and a database motif [43]. Below each 
sequence logo, the cell type, sequence set, motif name, and signifi-
cance of the TOMTOM match (ET) are displayed.
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in close spatial proximity (Figure 6). In HUVEC enhanc-
ers, for example, we find a significant number of activa-
tor protein 1 (AP-1) and ERG motif matches. AP-1 is a 
heterodimeric protein that recognizes and binds to the 
enhancer heptamer motif 5′-TGA[CG]TCA-3′. ERG 
is a subfamily of the ETS family of TFs, which have a 
strong 5′-GGAA-3′ core binding sequence within their 
binding motifs. The ERG subfamily includes TFs such 
as ERG and FLI1, which are known to be functionally 
active in HUVEC. Through our de novo motif analysis, 
we find these two classes of motifs are significantly co-
enriched, but the frequency of the combination depends 
on the relative orientation of these two motifs. Further-
more, sequence-specific constraints for the ERG binding 
motif are relaxed when an AP-1 motif is nearby. These 
results suggest a motif regulatory “grammar” governed 
by physical constraints that dictate the in  vivo spatial 
arrangements and frequencies of combinations of motifs, 
which is consistent with a previous report [26], and may 
uncover some of the non-canonical sequence determi-
nants that underly disease-associated SNPs. Similarly, 
another previous study showed the sequence-specific 
constraints of some TFs can decrease as a function of 
the number of co-occupying factors [27]. Although these 
motifs contain binding preferences of well-character-
ized TFs, most of them are novel, lacking any database 
matches. As a resource to the community, we provide all 
de novo discovered motifs in MEME Minimal Motif For-
mat (Additional file 4).
GWAS SNPs significantly overlap SEs and alter motifs 
outside of DHSs
Motivated by the co-occurrence of T2D GWAS SNP loci 
and islet SEs, we test whether GWAS SNPs associated 
with several diseases and traits are generally enriched 
in SEs. A SNP locus consists of a lead SNP and all 
SNPs in strong LD with that lead SNP (r2 ≥  0.8), care-
fully accounting for the possibility that the lead SNP is 
not causative but is instead in LD with the true, causa-
tive SNP. Indeed, SNP loci are enriched both inside and 
outside of DHSs in SEs, replicating previous disease- 
and trait-associated SNP enrichment in cell-specific 
enhancer states [2, 28], including rheumatoid arthritis in 
GM12878 (Figure 7, Additional file 2: Figure S13). While 
we know that SEs are enriched for SNPs associated with 
complex diseases, the mechanism by which these SNPs 
contribute to disease risk is not clear. One reasonable 
mechanism is through altering TF binding sites in SEs. 
To assess this idea, we also test for GWAS SNP enrich-
ment within cell identity motif sites in SEs. Interestingly, 
GWAS SNP loci are much more enriched and abundant 
in SE non-DHS cell identity motif sites than they are in 
SE DHS cell identity motif sites. We posit that our earlier 
proposition that SNPs are disrupting putative TF binding 
sites in less accessible chromatin portions of SEs may in 
fact be a prevalent mechanism for driving common dis-
eases. A previous study suggested that most non-coding 
GWAS SNP loci intersect DHS regions [29], but did not 
consider motifs in SEs that reside outside DHSs, as we 
do here. Our findings are consistent with another study 
that found enhancer-associated chromatin marks can be 
more informative for tissue-specific disease SNP enrich-
ments than DHSs can [30].
Although our analysis provides a possible mecha-
nism for many disease SNPs, several SNPs are left unac-
counted for. Notably, our motif sets are limited, including 
only motifs from two databases, which are far from 
complete and are missing motifs that were discovered 
through our de novo motif discovery analysis, for exam-
ple. Our GWAS analysis also focuses on motifs of activa-
tors, which excludes TFs like CTCF whose binding motif 
is slightly enriched in enhancers. We also do not consider 
Figure 6 De novo motif discovery in enhancer footprint sequences 
reveals novel binding patterns of well-characterized TFs. Motifs of 
known activators in the HUVEC, K562, HSMM, and HepG2 cell lines 
can co-occur together. For example, in the HUVEC enhancer footprint 
sequences, the ERG motif, a member of the ETS family that is char-
acterized by a “GGAA” binding paper, often co-occurs with the AP-1 
motif. In the presence of the AP-1 motif, the degree of resemblance 
of a predicted site to the ERG motif is weaker. SPI1, another member 
of the ETS family, shares a similar relationship with the GATA1 motif in 
K562. In other examples, activator TFs appear to often homodimerize 
and form palindromic motifs. Sequence logos of examples of de novo 
motifs in the cell types are displayed alongside, if available, CentriMo 
E-values and number of matches in SE DHS sequences (“Meth-
ods”). For two of the HepG2 examples, the motifs are so infrequent 
that CentriMo failed to find a significant number of matches in SE 
sequences.
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variants that generate new motif sites. A recent study, for 
example, showed that a small insertion introducing bind-
ing motifs can lead to the formation of an aberrant onco-
genic super-enhancer [31]. Including these other pieces 
of information may account for the remaining SNP loci.
Conclusions
In this study, we analyzed the motif architecture of SEs, 
which we hypothesized can distinguish SEs from TEs. 
In general, enhancers are highly enriched for TF binding 
sites, especially those corresponding to activators. SEs are 
characterized by multiple motif-rich DHSs in close spa-
tial proximity, unlike shorter TEs which typically have at 
most one DHS. SEs also display much higher H3K27ac 
ChIP-seq signal, a marker for active enhancers. This result 
complements a recent study which found that enhancer 
reporter activity from sequences in H3K27ac peaks 
within super enhancers is considerably stronger than 
enhancer reporter activity from sequences in H3K27ac 
peaks outside of super enhancers [32]. We conjecture that 
the exceptional length of SEs is in part due to the spatial 
coordination of accessible chromatin where clusters of 
activators can bind. Expression of tissue-specific TFs, par-
ticularly activators, also correlates with presence of their 
binding sites in enhancers that are active in that same tis-
sue. Although these TF binding sites are most enriched in 
the punctate DHSs, SEs contain dense clusters of motifs 
outside of their DHSs. Notably, the SE motif architecture 
within and outside DHSs is significantly correlated, sug-
gesting an orchestrated mechanism of regulation across 
the entire length of the element.
Through de novo motif discovery analysis in the motif-
rich DNase I footprint sequences, we identified non-
canonical binding sites and predicted which pairs of TFs 
bind adjacently more than expected by chance. Many of 
these composite motifs are not present in any motif data-
base, having only been identified in this study, revealing 
large gaps in current databases.
Disease-associated SNPs identified through GWAS are 
known to co-localize with SEs in a cell-specific manner, 
but the exact mechanism by which these SNPs perturb 
genome function is not well characterized. One pos-
sibility is that these SNPs are disrupting TF binding in 
regions of open chromatin. Indeed, we find that DHSs 
within SEs are modestly enriched for GWAS SNPs. Inter-
estingly, however, our most notable finding is that GWAS 
SNPs more often co-localize outside of the SE DHSs, and 
motif sites that are within SEs but outside of DHSs cap-
ture many of these SNPs. This finding may explain why 
a recent large study reported better GWAS SNP asso-
ciations with chromatin-marked enhancers versus DHSs 
[30].
Figure 7 SEs show significant enrichment of GWAS SNPs associated with diseases or quantitative in a cell-specific manner. Positions of index and 
tightly linked (r2 ≥ 0.8) SNPs for different diseases or traits (y-axis) are overlapped with those of DHSs within SEs, non-DHSs with SEs, and motif sites 
in either DHSs or non-DHSs within SEs for each cell type (x-axis). Only motifs from the cell-specific motif sets used to generate the motif density 
tracks in Figure 4 are considered for each cell type. Motif sites were identified with FIMO at the default threshold of p < 10−4. Text in the boxes indi-
cates the number of overlapping SNP loci in each cell type. Shading indicates the significance of SNP locus enrichment relative to a null distribution 
(“Methods”). Only SNPs that meet the genome-wide significance threshold (p < 5 × 10−8) are considered.
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The functional role of these motif sites in less accessible 
chromatin is not well-understood. They could represent 
actual binding sites, despite lacking the extreme chro-
matin openness marked by DHSs. From an evolutionary 
perspective, it is possible that common disease SNPs may 
be preferentially found in such sites because disruption 
of TF binding in the most highly accessible chromatin 
would not be normally tolerated in the population due 
to selective pressure. Another possibility is based on the 
idea that SEs are lineage-specifying regulatory hubs that 
orchestrate a chromatin environment that is permissive 
to rapid cellular response. The GWAS SNPs enriched in 
motifs in SEs but outside DHSs could represent response 
elements that become active (and potentially hypersen-
sitive to DNase I) in different developmental stages or 
under different physiologic conditions. Such a scenario 
would be an efficient solution to tune dynamic changes 
rapidly and precisely in lineage-specific gene expres-
sion, consistent with the rheostat model of SE function 
that was recently proposed [33]. Testing these hypotheses 
will require additional TF profiling experiments, such as 
ChIP-seq and DNase-seq, across diverse environmental, 
developmental, and genetic backgrounds.
Methods
DNase I hypersensitivity, chromatin state and gene 
expression profiling
Chromatin states and gene expression were integrated 
as previously described [3]. Sources of sequencing reads 
from ChIP-seq and RNA-seq experiments used in the 
integrative analysis are found in the supplementary mate-
rials of [3]. Single-hit DNase-seq data from the ENCODE 
Duke University group were used for the genome 
browser shots and calling DHSs. DHSs were based on 
narrow peak calls of single-hit DNase-seq data from the 
ENCODE Duke University group. Narrow peak files also 
contain the genome coordinates of the summits. Wiggle 
signal tracks for these single-hit data were also used for 
the UCSC genome browser shots.
Motif scanning and calculating motif enrichment
We performed position weight matrix (PWM) motif 
scanning of FASTA sequence sets using FIMO [34]. Motif 
occurrences were called at the default p value thresh-
old of 10−4. Based on empirical results, we found the 
default threshold to be a good compromise between a 
stringent threshold that called very few motif sites and 
a relaxed threshold that called too many motif sites, as 
well as computationally efficient. Motif enrichment in a 
set of sequences is calculated as the ratio of the number 
of occurrences of the motif in the set of sequences rela-
tive to the number of motif occurrences in dinucleotide 
shuffled versions of the sequences. Dinucleotide shuffled 
sequences were generated using the dinucleotide shuf-
fling script in the MEME Suite [35]. This measure of 
enrichment allows direct comparison between sequence 
sets of varying number of nucleotides.
We also performed PWM scanning using CentriMo 
[36], which computes the central enrichment of motifs. 
For each motif, CentriMo finds an optimal score above 
the minimum threshold 5 bits at which to call motifs. 
1  kbp sequences centered on DNase-seq peak summits 
in SEs or TEs were extracted from the hg19 reference 
genome as input sequences to CentriMo. CentriMo out-
puts log adjusted p-values measuring the significance of 
motif enrichment in the center of sequences.
When scanning sequences with known motifs, we take 
human or mouse motifs from the JASPAR 2014 [37] or 
the high-throughput SELEX [20] databases. We selected 
these two databases because of the quality of their bind-
ing models and their coverage of TFs. These two data-
bases contain 943 motifs altogether.
Motif enrichment heatmaps
Heatmaps plotting the enrichment of motifs in enhancer 
sequences were generated on a subset of the 943 motifs 
to focus on motifs that likely play an important role in 
enhancers and improve the visualization of the heatmaps. 
From the original 943 database motifs, we selected motifs 
that are highly (log2 fold enrichment >1.5 in at least one 
cell type) and differentially (log2 fold enrichment range 
>0.75) enriched in SE DHS sequences. We also select 
motifs that correspond to TFs that are expressed in any 
one of the nine cell types (>2 RPKM). Finally, we further 
condense the motifs by selecting motifs whose enrich-
ment in SE DHS sequences correlates positively (ρ  >  0) 
with the expression of the TF it corresponds to (Fig-
ure 2a), which we found to be an indication of activators. 
The remaining motifs are ordered using agglomerative 
clustering on the log2 fold enrichment values in SE DHSs. 
Agglomerative clustering was implemented using the 
aggExCluster method in the apcluster R package with the 
mutual pairwise similarities of data vectors as negative 
distances [38]. Visualization and clustering were based 
on log2 fold enrichment values instead of directly on fold 
enrichment values due to the relatively large range of fold 
enrichment values across all motifs (typically between 
1 and 8). Using log2 values makes direct comparisons 
between motifs more manageable across this range.
Assigning motifs to cells
For each cell type, we generated a list of activator motifs 
that are important in enhancers. These are the same 
motifs that we used for our motif density tracks (Fig-
ure 4b, Additional file 2: Figure S11) and GWAS enrich-
ment analysis (Figure 7, Additional file 2: Figure S13). The 
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selection procedure is similar to the filtering steps for 
the motif enrichment heatmaps. A motif is assigned to a 
cell type if its respective TF is expressed in that cell type 
(>2 RPKM), it is highly enriched in the central region 
of the cell’s SE DHS sequences (CentriMo log adjusted 
p-value < −50), and its enrichments in SE DHS sequences 
correlate positively with gene expression across the nine 
cell types (ρ > 0). If a motif has multiple versions in the 
databases, such as the DNA binding domain and full 
transcript versions in the high-throughput SELEX data-
base [20] we only select the motif with the lowest Cent-
riMo log adjusted p-value. The number of motifs in each 
set ranges from as few as 25 for H1 ES to as many as 56 
for HMEC and NHEK.
Aggregate histogram plots
We used the Homer annotatePeaks tool [39] to generate 
aggregate histogram plots documenting the dinucleotide 
frequency, motif density, and DNase-seq and H3K27ac 
ChIP-seq tag density ±1,500  bps with 10  bp bins rela-
tive to DNase-seq narrow peak summits overlapping 
SEs or TEs. ChIP tags were centered based on their esti-
mated ChIP-fragment length. DNase tags were kept in 
their original positions by fixing the estimated DNase-
fragment length to 1. Mappability (36 bp) and GERP [12] 
aggregate histogram plots were similarly generated with 
the bwtool aggregate command [40] instead.
De novo footprinting
De novo footprinting requires deep sequenced DNase-
seq data. Unfortunately, the data available are highly het-
erogeneous. Not only are the deep sequence DNase-seq 
datasets available at varying sequence depth, they are 
also generated by two different experimental protocols: 
a single-hit version [8] and a double-hit version [25] of 
DNase-seq. Therefore, we adopted four different meth-
ods to call footprints de novo.
Four of the nine cell types considered in this study 
have deep sequenced double-hit DNase-seq data (K562, 
HSMM, HepG2, HUVEC). Of these four, three were pre-
viously processed by a de novo footprinting algorithm 
that searches DHSs for locations with high footprint 
occupancy scores, and genome coordinates of the foot-
prints were made openly available [24]. For the remaining 
cell type, HUVEC, footprints were called on the double-
hit data with Wellington [41] at a stringent threshold of 
p < 10−20.
For the remaining five cell types, footprints were called 
on deep sequenced single-hit DNase-seq data, but these 
datasets were not sequenced as deeply as the double-hit 
for the other four cell types. We called footprints in four 
of the single-hit DNase-seq data with the “1D” version of 
Wellington on pooled replicates. Footprints were called 
at a threshold of p < 10−5, except for the GM12878 cell 
line for which we used a threshold of p < 10−10 due to the 
deeper sequencing depth available. For the remaining cell 
line, NHEK, the sequencing depth of the available data-
set was too shallow to reliably call footprints with Wel-
lington, so we extracted only high confidence footprints 
previously called by a Hidden Markov Model (HMM) 
algorithm [23], which were originally based in the hg18 
genome but later lifted over to the hg19 genome.
Footprints are further processed prior to downstream 
analysis by extending footprint genome coordinates 
equally on both ends by 5  bps (20  bps for HMM-based 
footprints) and then merging overlapping coordinates 
using the BEDTools [42] mergeBed tool with parameter 
d = 10 (d = 40 for HMM-based footprints).
Of the nine cell types considered in this study, only 
the K562 cell line had enough data to apply all four foot-
printing methods on. Hence, we applied all four foot-
printing methods on the K562 for comparison in the 
downstream de novo motif discovery (see next subsec-
tion). The thresholds and parameters were selected to 
yield sequence datasets of 5–10 million bps, which we 
found to be optimal for motif discovery.
De novo motif discovery
De novo motif discovery was applied to SE DHS 
sequences and enhancer footprint sequences in all 
enhancers using the EXTREME algorithm [19]. FASTA 
sequence sets were generated by extracting hg19 masked 
genome sequences from BED file coordinates using 
the BEDTools fastafrombed command [42]. SE DHS 
FASTA sequences were further preprocessed by replac-
ing instances of AAAAAAAA, ACACACAC, and their 
reverse complements with capital N’s. Such repetitive 
subsequences are ubiquitous throughout the genome 
and are often missed in the genome masking process. 
Masked sequences were inputted to the EXTREME pipe-
line with the parameters l  =  5 and q  =  0.02 (all other 
parameters were set to the default or recommended val-
ues). We selected these parameters empirically based on 
the quality of motifs generated. Although footprints were 
generated from a variety of algorithms and experimen-
tal protocols, EXTREME can still find a consistent set 
of high-quality enhancer-associated motifs (Additional 
file 2: Figure S12). Discovered motifs were compared to 
known motifs from the JASPAR 2014 [37] or the high-
throughput SELEX [20] databases using TOMTOM [43] 
keeping only significant matches (E < 0.1).
GWAS variant enrichment
We calculated GWAS variant enrichment exactly as we 
did in our previous study of SEs [3] on an updated set 
of SNPs from the NHGRI GWAS catalog (http://www.
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genome.gov/gwastudies/; downloaded on October 9, 
2014). Briefly, we calculated enrichment by performing 
a permutation test that measures SNP loci and enhancer 
overlaps as previously described [2]. A SNP locus con-
sists of a lead SNP and all SNPs in strong LD with that 
lead SNP. SNPs in LD with the lead SNP were defined as 
those with r2 ≥ 0.8. We ran 10,000 iterations of the per-
mutation test and estimated the maximal P-value as the 
number of permutations equal to or greater than the 
observed overlap value plus one divided by the number 
of iterations plus one (10,001). Our enrichment analysis 
was performed on both the entire set of NHGRI GWAS 
catalog SNPs per trait and a filtered subset of genome-
wide significant SNPs (p < 5 × 10−8) per trait.
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